Noninvasive Prenatal Tests Present Lucrative Growth Prospects for Prenatal & Maternal Diagnostic Market, Says Kelly Scientific in Report Available at

05 Oct 2016 • by Natalie Aster

LONDON – Nowadays, the mortality rate of newborns especially in developing economies is very high: annually around 5 million babies from 140 million babies born worldwide die in the first month of life. For instance, nearly 5-15% of sick newborns in India suffer from metabolic disorders. This points out the rising necessity for newborns screening to prevent disability and early death.

Worldwide, such techniques as ultrasound imaging (for detection of different birth defects) and maternal serum marker screening are used in prenatal care mainly during the 1st and/or 2nd trimesters. But unfortunately these techniques have rather high false positive rates (approximately 2%-7%). If a significant risk of aneuploidy of a fetus is diagnosed, then invasive approaches for diagnosis are recommended, for example, amniocentesis or chorionic villus sampling (CVS).

At present, ultrasound is used around five times per pregnancy before childbirth. The fetal ultrasound screening market is predicted to increase considerably through 2021. Fetal MRI prenatal screening is done only in case the ultrasound screening gives an ambiguous result and also in order to detect CNS disorders during the 2nd trimester.

Noninvasive prenatal tests (NIPTs) are recognised as the future of prenatal screening. The revenues of the NIPTs market could possibly surpass the revenues of the traditional maternal serum tests revenues.

Today, newborn screening is accepted as a healthy policy in around 52 countries, including the USA, the UK, Japan and Australia and the majority of the western European countries, where newborn screening has been a well-entrenched routine of newborn care for already three decades. Meantime, in the Asian countries, including Philippines, China and Thailand admirable newborn screening programs have been developed in a relatively short period of time.

New research report “Global Prenatal & Maternal Diagnostic Market to 2021” prepared by Kelly Scientific Publications includes an all-encompassing review of the global market for prenatal and maternal diagnostics. The report offers reliable info on all existing kinds of tests, includes a reviews of new product launches and the latest strategies adopted. Moreover, the study investigates the current scenario across the key country-wide markets and contains a detailed market segmentation analysis. The report also traces light on the major competitive pressures and gives details on top companies active in the market. The top growth driving factors, challenges and hinders are canvassed in the report as well. In addition, an all-round future outlook for the marketplace through 2021 is at hand in this report.

To find other research reports by the publisher follow to Kelly Scientific Publications page.


The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970